Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01301066 · ClinicalTrials.gov registry record · Phase 4

A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects

A Phase 4 study of Dyslipidemia, sponsored by Kowa Research Institute.

Completed
Registry status
Phase 4
Development phase
252
Enrollment target
20
Study locations

NCT01301066 is a Phase 4 study of Dyslipidemia that has completed, run by Kowa Research Institute. The registered enrollment target is 252 participants, below the 357-participant average among 40 other Dyslipidemia trials with a reported enrollment target (29% lower). The trial reports 20 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01301066, a Phase 4 study of Dyslipidemia, has completed, sponsored by Kowa Research Institute.

COMPLETED
Registry status
Phase 4
Development phase
252 participants
Enrollment target
20
Study locations

Study Summary

A 12-Week, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study.

Conditions Studied

Dyslipidemia

Interventions

  • DRUG Pravastatin
  • DRUG Pitavastatin

Study Locations (20)

Florida

  • - Coral Gables
  • - Fort Lauderdale
  • - Ft. Pierce
  • - Miami
  • - Miami Beach
  • - Tampa
  • - Vero Beach

California

  • - Beverly Hills
  • - Costa Mesa
  • - Long Beach
  • - Los Angeles
  • - Newport Beach
  • - San Francisco

Georgia

  • - Atlanta
  • - Decatur

Arizona

  • - Phoenix

District of Columbia

  • - Washington D.C.

Massachusetts

  • - Springfield

Michigan

  • - Berkley

Missouri

  • - St Louis

Trial Details

FieldValue
Enrollment Target 252 participants
Start Date 2010-12
Est. Completion 2013-03
Phase Phase 4

Sponsor

Kowa Research Institute

44 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01301066

The ClinicalTrials.gov registry entry for NCT01301066 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 357-participant average among 40 other Dyslipidemia trials with a reported enrollment target (29% lower). The listed sponsor is Kowa Research Institute, which has 44 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dyslipidemia appearing as the primary indexed condition, and to 2 interventions - of which Pravastatin is the first listed.

NCT01301066 reports 20 study locations spanning 8 distinct geographic areas - top geographies include Florida, California, Georgia.

Frequently Asked Questions

What is clinical trial NCT01301066 about?

NCT01301066 is a clinical study titled "A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects". A 12-Week, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study.

What is the current status of trial NCT01301066?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 252 participants. The study started on 2010-12. Estimated completion is 2013-03.

What conditions does trial NCT01301066 study?

This clinical trial studies the following conditions: Dyslipidemia.

What interventions are being tested in trial NCT01301066?

The interventions under investigation include: Pravastatin (DRUG), Pitavastatin (DRUG).

Who is sponsoring clinical trial NCT01301066?

This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01301066 being conducted?

This trial has 20 study locations across Arizona, California, District of Columbia, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dyslipidemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Dyslipidemia

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.